Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00114608 · ClinicalTrials.gov registry record · Phase 1

Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot

A Phase 1 study, sponsored by University at Buffalo.

Completed
Registry status
Phase 1
Development phase
40
Enrollment target

NCT00114608 is a Phase 1 study that has completed, run by University at Buffalo. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00114608, a Phase 1 study, has completed, sponsored by University at Buffalo.

COMPLETED
Registry status
Phase 1
Development phase
40 participants
Enrollment target

Study Summary

Electrical stimulation of the foot can increase blood flow out of the leg. This increased blood flow can prevent blood clots from forming in the leg veins. Blood clots in the leg veins can break off and form life-threatening blood clots in the lungs. Intermittent external pneumatic (air) compression of the foot is already used to increase blood flow in at risk patients. Hypothesis: Electrical stimulation of the foot increases blood flow out of the legs to the same degree as intermittent external pneumatic (air) compression of the foot.

Interventions

  • DEVICE The Focus™ Neuromuscular Stimulation System

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2005-06
Est. Completion 2007-07
Phase Phase 1

Sponsor

University at Buffalo

67 total trials

What the Registry Record Tells You About NCT00114608

The ClinicalTrials.gov registry entry for NCT00114608 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University at Buffalo, which has 67 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which The Focus™ Neuromuscular Stimulation System is the first listed.

NCT00114608 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00114608 about?

NCT00114608 is a clinical study titled "Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the Foot". Electrical stimulation of the foot can increase blood flow out of the leg. This increased blood flow can prevent blood clots from forming in the leg veins. Blood clots in the leg veins can break off and form life-threatening blood clots in the lungs. Intermittent external pneumatic (air) compressi...

What is the current status of trial NCT00114608?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2005-06. Estimated completion is 2007-07.

What interventions are being tested in trial NCT00114608?

The interventions under investigation include: The Focus™ Neuromuscular Stimulation System (DEVICE).

Who is sponsoring clinical trial NCT00114608?

This trial is sponsored by University at Buffalo, which has 67 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.